Glenny Corp. S.A. — Buenos Aires

Public research footprint of Glenny Corp. S.A., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Chronic Kidney Disease · Atherosclerotic Cardiovascular Disease (ASCVD) · Chronic Obstructive Pulmonary Disease (COPD)

Recently updated registry entries

NCT07241390 — A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With… (Recruiting)
NCT07321886 — A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without… (Recruiting)
NCT07165028 — A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Glenny Corp. S.A.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.